HB 728 Maryland House of Delegates · 2025 Regular Session

Opioid Restitution Fund - Authorized Uses

HB 728 redefines the allowable uses of Maryland's Opioid Restitution Fund to explicitly permit funding for the operating expenses and personnel costs of the Opioids Enforcement Unit within the Office of the Attorney General. This unit conducts investigations and enforcement actions related to recovering funds from opioid-related judgments and settlements. The bill specifically amends Section 7-331(f)(5) of the Maryland Annotated Code to add this provision, while maintaining the Fund's existing uses for prevention, treatment, recovery, and harm reduction programs. It directly affects the Attorney General's Office and ensures enforcement activities can be supported using restitution funds.
Bill status signed all 5 stages cleared
Introduction
Jan 2025
Committee Review
Apr 2025
House of Delegates Passage
Apr 2025
Senate Passage
Apr 2025
Signed into Law
May 2025
Introduced Jan 27, 2025 Signed May 20, 2025
Maddy AI version diff · 1 comparison

What changed between versions

First - Opioid Restitution Fund - Authorized Uses Third - Opioid Restitution Fund - Authorized Uses · 3 edits
MINOR
The bill was amended to add new sponsors, update the bill status to show it was adopted, and add a new reporting requirement for the Attorney General's Opioids Enforcement Unit. The most significant substantive change is the addition of a new subsection (K) requiring the Attorney General to report quarterly on enforcement activities, including the number of investigations, lawsuits filed, and their dispositions.
Scope change
The bill's scope was expanded to include a new quarterly reporting requirement for the Opioids Enforcement Unit, while the core provisions regarding the Opioid Restitution Fund and its authorized uses remained substantively unchanged.
REQUIREMENT

Added a new subsection (K) requiring the Attorney General to submit quarterly reports to the Governor and General Assembly on Opioids Enforcement Unit activity, including investigation counts, lawsuits filed, and case dispositions, starting on or before October 1, 2025.

TECHNICAL

Added multiple new sponsors to the bill (Delegates Pena-Melnyk, Cullison, Alston, Bagnall, Bhandari, Guzzone, Hill, S. Johnson, Kaiser, Kerr, Lopez, Martinez, Taveras, Woods, Woorman, and Ross).

Updated bill status information to reflect committee approval and House adoption with second reading on March 3, 2025.

Floor votes · Senate Mar 16, 2025 · House of Delegates Mar 4, 2025

How they voted

3313
Passed
Total votes 46
Mar 16, 2025
D Democratic33
33 Yea
100% Yea
R Republican13
13 Nay
100% Nay
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
15
Key actions
10
Committee
6
May 20, 2025
Signed into law
Approved by the Governor - Chapter 700
executive
Apr 3, 2025
Lower · Passed
Returned Passed
lower
Apr 3, 2025
Upper · Passed
Third Reading Passed
upper
Apr 2, 2025
Upper · Passed
Favorable Adopted
upper
Mar 31, 2025
Upper · Passed
Favorable Report by Finance
upper
Mar 17, 2025
Committee
Referred Finance
upper
Mar 16, 2025
Senate · Passed
Senate Vote: pass (33-13)
senate
Mar 14, 2025
Lower · Passed
Third Reading Passed
lower
Mar 13, 2025
Lower · Passed
Favorable with Amendments {
lower
Mar 13, 2025
Lower · Passed
Favorable with Amendments Report by Health and Government Operations
lower
Mar 4, 2025
House Of Delegates · Passed
House of Delegates Vote: pass (101-36-2)
house of delegates
Jan 27, 2025
Committee
First Reading Health and Government Operations
lower
16 primary · 0 co-sponsors

Sponsors